NCT03052127: A reported trial by Aura Biosciences
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03052127 |
|---|---|
| Title | A Phase 1B/2 Open-Label, Ascending Single and Repeat Dose Clinical Trial Designed to Evaluate the Safety and Efficacy of Light-activated AU-011 for the Treatment of Subjects With Small Primary Choroidal Melanoma |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 27, 2017 |
| Completion date | Jan. 26, 2021 |
| Required reporting date | Jan. 26, 2024, midnight |
| Actual reporting date | Dec. 19, 2023 |
| Date last checked at ClinicalTrials.gov | Jan. 7, 2026 |
| Days late | None |